Abstract
Pathological hubs in the brain networks of epilepsy patients are hypothesized to drive seizure generation and propagation. In epilepsy-surgery patients, these hubs have traditionally been associated with the resection area: the region removed during the surgery with the goal of stopping the seizures, and which is typically used as a proxy for the epileptogenic zone. However, recent studies hypothesize that pathological hubs may extend to the vicinity of the resection area, potentially complicating post-surgical seizure control. Here we propose a neighbourhood-based analysis of brain organization to investigate this hypothesis. We exploit a large dataset of presurgical MEG (magnetoencephalography)-derived whole-brain networks from 91 epilepsy-surgery patients. Our neighbourhood-focus is two-fold. Firstly, we propose a partition of the brain regions into three sets, namely resected nodes, their neighbours, and the remaining network nodes. Secondly, we introduce generalized centrality metrics that describe the neighrbourhood of each node, providing a regional measure of hubness. Our analyses reveal that both the resection area and its neighborhood present large hub-status, but with significant variability across patients. For some, hubs appear in the resection area; for others, in its neighborhood. Moreover, this variability does not correlate with surgical outcome. These results highlight the potential of neighborhood-based analyses to uncover novel insights into brain connectivity in brain pathologies, and the need for individualized studies, with large-enough cohorts, that account for patient-specific variability.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
A.P.M. acknowledges financial support by the Ramon y Cajal program of the Spanish Ministry of Science and Innovation (grant RYC2021-031241-I), and from the Spanish Research Agency, Project PID2020-113681GBI00, financed by MICIN/AEI/10.13039/501100011033. A.P.M. and I.N. were supported by ZonMw and the Dutch Epilepsy Foundation, project number 95105006, and Dutch Epilepsy Foundation project 14-16 (I.N.). L.D.G. acknowledges financial support from the Clinical Neurophysiology Department (KNF) at the Amstedam University Medical Center (AUMC). The funding sources had no role in study design, data collection and analysis, interpretation of results, decision to publish, or preparation of the manuscript. N.D. acknowledges funding by the Swiss National Science Foundation (SNSF) under project funding ID: 200021 207537 and by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy EXC2181/1-390900948 (the Heidelberg STRUCTURES Excellence Cluster). This work was partially supported by a grant from the Simons Foundation (G.B.). G.B. and A.P.M. would like to thank the Isaac Newton Institute for Mathematical Sciences, Cambridge, for support and hospitality during the programme Hypergraphs: Theory and Applications, where work on this paper was undertaken. This work was supported by EPSRC grant EP/R014604/1.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
A waiver of ethical review was obtained from the institutional review board (Medisch Ethische Toetsingscommissie Vrij Universiteit Medical Center) as no rules or procedures were imposed other than routine clinical care.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* apmillan{at}ugr.es
Data Availability
The data used for this manuscript are not publicly available because the patients did not consent for the sharing of their clinically obtained data. Requests for access to the data should be directed to the corresponding author.
